CLEVELAND, Sept. 16 /PRNewswire-FirstCall/ -- DATATRAK International, a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the Company will be exhibiting and presenting at the 2008 Society of Clinical Data Management (SCDM) Conference that will be held Sunday, September 21 through Wednesday, September, 24 in Dallas, Texas.
Dr. Jeffrey Green, Chief Executive Officer of DATATRAK, was invited to share his insight and expertise and will be presenting a session on calculating the ROI of EDC, Monday, September 22 from 1:30 - 3:00 p.m. His presentation will illustrate how an eClinical solution can positively impact the quality, time and cost of a clinical trial. Plus, he'll demonstrate how instant access to trial data can address the growing safety issues of drugs being tested.
He will be available in the DATATRAK Booth (#115) following his presentation to answer follow-up questions. In addition, DATATRAK representatives will be available to demonstrate the new functionality and features found in v7.0 of DATATRAK's eClinical Solution. This soon-to-be-released version has enhanced reporting and language capabilities that will allow clinical data managers easier access to study trial information.
The Society for Clinical Data Management (SCDM) is a non-profit professional society founded to advance the discipline of Clinical Data Management. The binding interest of all members is quality clinical data management practices.
About DATATRAK International:
DATATRAK International, Inc. is a worldwide technology company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry. The Company delivers a complete portfolio of software products that were created in order to accelerate clinical research data from investigative sites to clinical trial sponsors and ultimately the FDA, faster and more efficiently than manual methods or loosely integrated technologies. The DATATRAK eClinical(TM) software suite can be deployed worldwide through an ASP offering or in a licensed Enterprise Transfer ASP model that fully empowers clients to design, set up and manage their clinical trials independently. The DATATRAK software suite and its earlier versions have successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK International, Inc.'s product suite has been utilized in some aspect of the clinical development of 16 separate drugs and one medical device that have received regulatory approval from either the United States Food and Drug Administration or counterpart European bodies. DATATRAK International, Inc. has offices located in Cleveland, Ohio and Bryan, Texas. Its common stock is listed on the NASDAQ Stock Market under the ticker symbol "DATA". Visit the DATATRAK International, Inc. web site at http://www.datatrak.net/ .
